EUVIMEDEUVIMED entdecken
Crossref

Biomimetic Nanoplatform Integrating CeO₂ Nanozymes and Anti‐Inflammatory Peptides for Osteoarthritis Therapy

Chengli Yang, Xukun Liao, Yilin Wang, Wen Zhong, Feier Xian, Mei Gao, Min Zeng, Jiehao Chen, Xiaoting Chen, Ming Li, Kai Zhou iD

Small · 2025-08 · 21 (32)

DOI: 10.1002/smll.202502677 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Small, online erschienen am 20.05.2025. Verfasst von Chengli Yang und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, Clinical Research Center of Integrated Traditional Chinese and Western Medicine, The Affiliated Hospital of Guizhou Medical U…. Hauptthemen laut MEDLINE: Osteoarthritis, Cerium, Anti-Inflammatory Agents, Peptides. Die Arbeit wurde bisher 28-mal zitiert (Crossref) und nennt 40 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Sichuan University-Dazhou Municipal People's Government School-city Cooperation Special Fund Project, Science and Technology Department of Sichuan Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Osteoarthritis (OA) affects more than 250 million people worldwide, with current therapies focused primarily on symptom management rather than addressing underlying disease mechanisms. Here, MHTCK, a novel biomimetic nanoplatform is presented that uniquely integrates CeO₂ nanozymes with the anti‐inflammatory peptide KAFAK through the fusion of a macrophage‐synoviocyte membrane coating. Physicochemical characterization reveals that MHTCK maintains nanostability with a size of ≈ 200 nm and a surface charge of −30 mV. Compared with conventional antioxidant nanoparticles, the platform demonstrated superior cellular uptake in synoviocytes (2.8‐fold), chondrocytes (3.2‐fold), and macrophages (4.1‐fold). In vitro studies revealed that MHTCK effectively scavenged multiple ROS species by targeting mitochondria while preserving mitochondrial function as evidenced by the maintenance of ATP production, and promotion of M2 macrophage polarization. The biomimetic membrane coating enabled prolonged joint retention of up to 10 days postinjection through specific tissue‐targeting mechanisms, significantly improving pain thresholds and cartilage preservation in an OA rat model. This work demonstrates how rational integration of nanozyme technology with peptide therapeutics in a biomimetic delivery system can effectively modulate both oxidative stress and inflammation in OA, while maintaining cellular bioenergetics, providing new insights for developing targeted nanotherapeutics for inflammatory joint diseases.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

OsteoarthritisCeriumAnti-Inflammatory AgentsPeptidesBiomimeticsNanoparticlesBiomimetic MaterialsAnimalsRatsMacrophagesHumansRats, Sprague-DawleyReactive Oxygen SpeciesChondrocytes

Stichwörter der Autor:innen

cell membrane biomimeticsmacrophagesnanozymesosteoarthritisoxidative stress

Substanzen

Ceriumceric oxideAnti-Inflammatory AgentsPeptidesReactive Oxygen Species

Autor:innen und Institutionen

  • Department of Pharmacy, Clinical Research Center of Integrated Traditional Chinese and Western Medicine, The Affiliated Hospital of Guizhou Medical University, Guizhou, 550004, P. R. China.
  • West China School of Medicine, Sichuan University, Chengdu, 610040, P. R. China.
  • Animal Experiment Center, West China Hospital/West China School of Medicine, Sichuan University, Chengdu, 610040, P. R. China.
  • Department of Orthopedics, West China Hospital, Sichuan University, 37# Wuhou Guoxue Road, Chengdu, 610040, P. R. China.

ORCID-Profile: Kai Zhou

Förderung

  • National Natural Science Foundation of China
  • Sichuan University-Dazhou Municipal People's Government School-city Cooperation Special Fund Project
  • Science and Technology Department of Sichuan Province
  • Health Commission of Sichuan Province
  • Second Affiliated Hospital of Harbin Medical University
  • Guizhou Provincial Science and Technology Department

Zitieren

APA

Yang, C., Liao, X., Wang, Y., Zhong, W., Xian, F., Gao, M., Zeng, M., Chen, J., Chen, X., Li, M., & Zhou, K. (2025). Biomimetic Nanoplatform Integrating CeO₂ Nanozymes and Anti‐Inflammatory Peptides for Osteoarthritis Therapy. Small, 21(32). https://doi.org/10.1002/smll.202502677

Vancouver

Yang C, Liao X, Wang Y, Zhong W, Xian F, Gao M, et al. Biomimetic Nanoplatform Integrating CeO₂ Nanozymes and Anti‐Inflammatory Peptides for Osteoarthritis Therapy. Small. 2025;21(32). doi:10.1002/smll.202502677

BibTeX
@article{Yang2025,
  author = {Yang, Chengli and Liao, Xukun and Wang, Yilin and Zhong, Wen and Xian, Feier and Gao, Mei and Zeng, Min and Chen, Jiehao and Chen, Xiaoting and Li, Ming and Zhou, Kai},
  title = {Biomimetic Nanoplatform Integrating CeO₂ Nanozymes and Anti‐Inflammatory Peptides for Osteoarthritis Therapy},
  journal = {Small},
  year = {2025},
  volume = {21},
  number = {32},
  doi = {10.1002/smll.202502677}
}
Kostenlos starten →